DK1917026T3 - Lipid associeret vævsfaktor til anvendelse som topisk antihæmorragisk middel - Google Patents

Lipid associeret vævsfaktor til anvendelse som topisk antihæmorragisk middel

Info

Publication number
DK1917026T3
DK1917026T3 DK06776572.7T DK06776572T DK1917026T3 DK 1917026 T3 DK1917026 T3 DK 1917026T3 DK 06776572 T DK06776572 T DK 06776572T DK 1917026 T3 DK1917026 T3 DK 1917026T3
Authority
DK
Denmark
Prior art keywords
lipid
tissue factor
associated tissue
antihemorrhagic agent
topical
Prior art date
Application number
DK06776572.7T
Other languages
English (en)
Inventor
O Egea Javier Pedre
Catas S Luis Caveda
Original Assignee
Thrombotargets Europe Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thrombotargets Europe Sl filed Critical Thrombotargets Europe Sl
Application granted granted Critical
Publication of DK1917026T3 publication Critical patent/DK1917026T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK06776572.7T 2005-08-03 2006-08-02 Lipid associeret vævsfaktor til anvendelse som topisk antihæmorragisk middel DK1917026T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05380179A EP1749536A1 (en) 2005-08-03 2005-08-03 Activated factor X stimulants as new antihemorrhagic agents for topical use
PCT/EP2006/007660 WO2007014771A1 (en) 2005-08-03 2006-08-02 Stimulators of factor x activated (fxa) as new topical antihemorrhagic agents

Publications (1)

Publication Number Publication Date
DK1917026T3 true DK1917026T3 (da) 2014-06-10

Family

ID=35916272

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06776572.7T DK1917026T3 (da) 2005-08-03 2006-08-02 Lipid associeret vævsfaktor til anvendelse som topisk antihæmorragisk middel

Country Status (13)

Country Link
EP (3) EP1749536A1 (da)
JP (2) JP5268638B2 (da)
KR (1) KR101362993B1 (da)
CN (1) CN101291686B (da)
AU (1) AU2006274979B2 (da)
BR (1) BRPI0616535B8 (da)
CA (1) CA2617534C (da)
DK (1) DK1917026T3 (da)
ES (1) ES2468225T3 (da)
HK (1) HK1119569A1 (da)
PL (1) PL1917026T3 (da)
TW (2) TW200744633A (da)
WO (2) WO2007014772A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772371B2 (en) * 2005-08-03 2010-08-10 Thrombotargets Corporation Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents
EP2745852A1 (en) * 2012-12-21 2014-06-25 Thrombotargets Europe, S.L. Sealant compositions
EP2759305A1 (en) * 2013-01-24 2014-07-30 Thrombotargets Europe, S.L. Hemostatic compositions
CN110133303B (zh) * 2019-05-13 2023-04-07 深圳优迪生物技术有限公司 凝血酶原时间测定试剂及其应用
CN112433057B (zh) * 2020-11-10 2023-06-09 北京美创新跃医疗器械有限公司 一种狼疮抗凝物的筛选试剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721618A (en) * 1983-06-27 1988-01-26 Queen's University At Kingston Method for controlling bleeding
EP0266993B1 (en) * 1986-11-04 1995-04-05 Genentech, Inc. Method and therapeutic compositions for the treatment of bleeding disorders
US5017556A (en) * 1986-11-04 1991-05-21 Genentech, Inc. Treatment of bleeding disorders using lipid-free tissue factor protein
US6239101B1 (en) * 1989-07-05 2001-05-29 Oklahoma Medical Research Foundation Thrombin binding polypeptides
US6238875B1 (en) * 1991-03-12 2001-05-29 The Scripps Research Institute Diagnostic methods useful in the characterization of lymphoproliferative disease characterized by increased EPR-1
WO1993009804A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Serine protease derived-polypeptides and anti-peptide antibodies, systems and therapeutic methods for inhibiting coagulation
WO1994002172A1 (en) * 1992-07-24 1994-02-03 Oklahoma Medical Research Foundation Blockade of protein c activation reduces microvascular surgical blood loss
US5441759A (en) * 1992-09-03 1995-08-15 Sherwood Medical Company Method to stabilize TDMAC heparin coating
AU716282B2 (en) * 1995-06-07 2000-02-24 Johnson & Johnson Research Pty. Limited CDR-grafted anti-tissue factor antibodies and methods of use thereof
JP2002520053A (ja) * 1998-07-15 2002-07-09 ジェネンテック・インコーポレーテッド 凝固因子ｆｖｉｉ／ｆｖｉｉａに対する向上した親和性を持つ組織因子タンパク質変異体
EP1051620B1 (en) * 1998-10-30 2006-06-07 Jonathan L. Miller Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
AU2002211686A1 (en) * 2000-10-13 2002-04-22 On Site Gas Systems, Inc. Bandage using molecular sieves
US7015193B2 (en) * 2001-04-20 2006-03-21 University Of Vermont Compositions and methods to control bleeding
TWI338009B (en) * 2001-10-29 2011-03-01 Genentech Inc Antibodies for inhibiting blood coagulation and methods of use thereof
WO2004039842A2 (en) * 2002-10-31 2004-05-13 Novo Nordisk A/S Humanized tissue factor antibodies
CA2570566A1 (en) * 2004-06-25 2006-01-12 Altor Bioscience Corporation Production of tissue factor in plants

Also Published As

Publication number Publication date
ES2468225T3 (es) 2014-06-16
KR20080043324A (ko) 2008-05-16
CN101291686B (zh) 2013-03-13
EP1917026B1 (en) 2014-03-05
BRPI0616535B8 (pt) 2021-05-25
WO2007014771A1 (en) 2007-02-08
AU2006274979B2 (en) 2012-12-13
BRPI0616535B1 (pt) 2019-11-12
BRPI0616535A2 (pt) 2011-06-21
JP2009503008A (ja) 2009-01-29
EP1917026A1 (en) 2008-05-07
TW200744628A (en) 2007-12-16
PL1917026T3 (pl) 2014-08-29
CA2617534A1 (en) 2007-02-08
JP5268638B2 (ja) 2013-08-21
ES2468225T9 (es) 2014-10-24
JP2009503009A (ja) 2009-01-29
CA2617534C (en) 2016-07-05
TW200744633A (en) 2007-12-16
KR101362993B1 (ko) 2014-02-21
WO2007014772A2 (en) 2007-02-08
HK1119569A1 (en) 2009-03-13
TWI441645B (zh) 2014-06-21
EP1749536A1 (en) 2007-02-07
AU2006274979A1 (en) 2007-02-08
WO2007014772A3 (en) 2007-04-12
EP1917026B9 (en) 2014-06-18
CN101291686A (zh) 2008-10-22
EP1915175A2 (en) 2008-04-30

Similar Documents

Publication Publication Date Title
BRPI0722082A2 (pt) Ligantes para imagiologia da inervação cardíaca
DK2291368T3 (da) Substitueret gamma-lactam som terapeutisk middel
DK1856042T3 (da) Substituerede gamma-lactamer som terapeutiske midler
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DK1871181T3 (da) Kosttilskud til HIV-patienter
DK2131813T3 (da) Topiske, farmaceutiske formuleringer
HK1153661A1 (en) Oil-in-water type topical agent for skin
FI20065388A0 (fi) Betuliiniperäiset yhdisteet antimikrobisina aineina
NO20090724L (no) Benzylaminer, fremgangsmåte for fremstilling av slike, og anvendelse av dem som betennelseshemmende midler
FI20041129A0 (fi) Tioksotiatsolidinoniyhdisteitä lääkkeinä käytettäviksi
FR2902340B1 (fr) Composition cosmetique a usage topique comprenant du wasabi
DK1917026T3 (da) Lipid associeret vævsfaktor til anvendelse som topisk antihæmorragisk middel
DK2041128T3 (da) Substituerede gamma-lactamer som terapeutiske agenser
ES1059333Y (es) Protector-expositor removible para pilares
ES1060453Y (es) Elementos para expositor desmontable
ES1062588Y (es) Suela para calzado
ATE507826T1 (de) Formulierung für aviptadil
DK2207419T3 (da) Skumstabiliserende middel til en sterilisationsssammensætning
ES1064021Y (es) Piso para calzado
ES1065168Y (es) Soporte para biberon
ES1059548Y (es) Talonera perfeccionada para calcetines
ES1059451Y (es) Pie de apoyo para semirremolque
GB0517519D0 (en) Topical prostaglandin formulation
ITBO20060738A1 (it) Calzatura a doppio uso
ES1059344Y (es) Tahali para porras